Detoxing the Spike

I thought I’d share this published paper by Dr Peter McCullough on his detox recommendations. I’m sure there are a variety of opinions on this, but it seems simple and many may find it helpful. If you know someone that participated in the worldwide experimental injection and is struggling with health issues they previously did not have, this might be worth looking into.

https://zenodo.org/record/8286460

I’ve copied the text from the above link in the event that it is removed at some point.

Clinical Rationale for SARS-CoV-2 Base Spike Protein Detoxification in Post COVID-19 and Vaccine Injury Syndromes

 McCullough, Peter A; Wynn, Cade; Procter, Brian C

Project leader(s)

McCullough, Peter A

The spike protein is responsible for the pathogenicity of the SARS-CoV-2 infection and drives the development of adverse events, injuries, disabilities, and death after vaccination through immunologic and thrombotic mechanisms. The long-lasting spike protein has been found in the brain, heart, liver, kidneys, ovaries, testicles and other vital organs at autopsy in cases of death after vaccination.  In the case of vaccine-induced thrombotic injury, the spike protein has been found within the blood clot itself.  Thus, there is strong rationale for considering residual SARS-CoV-2 spike protein as a treatment target in post COVID-19 and vaccine injury syndromes. The spike protein participates directly in pathophysiology, incites inflammation, and propels thrombosis. While specific syndromes (cardiovascular, neurological, endocrine, thrombotic, immunological) will require additional therapies, we propose the clinical rationale for a base detoxification regimen of oral nattokinase, bromelain, and curcumin for patients with post-acute sequalae from SARS-CoV-2 infection and COVID-19 vaccination.

The empiric regimen can be continued for 3-12 months or more and be guided by clinical parameters:

-Nattokinase 2000 FU (100) mg orally twice a day without food

-Bromelain 500 mg orally once a day without food

-Curcumin 500 mg orally twice a day (nano, liposomal, or with piperine additive suggested)

No therapeutic claims can be made for this regimen because it has not been tested in large, prospective, double-blind, placebo controlled randomized trials.  No such studies are planned or funded currently by federal or institutional sponsors.  The main caveats are bleeding and allergic reactions.  The regimen can be used in addition to antiplatelet and antithrombic agents, however, caution is advised with respect to monitoring bleeding risks.

McCullough PA, Wynn C, Procter BC. Clinical Rationale for SARS-CoV-2 Base Spike Protein Detoxification in Post COVID-19 and Vaccine Injury Syndromes. Journal of American Physicians and Surgeons Volume 28 Number 3 Fall 2023, 90-93.

Becky Hastings collects information on health and tries her best to discover and share truth. By God’s grace, through Jesus Christ, I was saved, blessed with a husband of over 40 years, and five precious babies all grown up. I now get to delight as ten grandchildren grow! Together we can help each other discover a healthy path in this crazy upside down world.